トゥレット症候群：治療薬の治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tourette Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Tourette Syndrome to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Tourette Syndrome to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Tourette Syndrome 23
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Tourette Syndrome Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Tourette Syndrome 30
May 28, 2014: Psyadon Announces the Opening of a New Clinical Trial of Ecopipam for the Treatment of Tourette’s Syndrome in Children Ages 7-17 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Otsuka Holdings Co., Ltd. 31
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 31
Neurocrine Biosciences, Inc. 32
Clinical Trial Overview of Neurocrine Biosciences, Inc. 32
Psyadon Pharmaceuticals, Inc. 33
Clinical Trial Overview of Psyadon Pharmaceuticals, Inc. 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
C. H. Boehringer Sohn AG & Co. KG 35
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Valeant Pharmaceuticals International, Inc. 37
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 37
Tasly Pharmaceuticals, Inc. 38
Clinical Trial Overview of Tasly Pharmaceuticals, Inc. 38
NeuroSearch A/S 39
Clinical Trial Overview of NeuroSearch A/S 39
Auspex Pharmaceuticals, Inc. 40
Clinical Trial Overview of Auspex Pharmaceuticals, Inc. 40
Clinical Trial Overview of Top Institutes / Government 41
National Institute of Neurological Disorders and Stroke 41
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 41
Yale University 42
Clinical Trial Overview of Yale University 42
National Center for Research Resources 43
Clinical Trial Overview of National Center for Research Resources 43
National Institute of Mental Health 44
Clinical Trial Overview of National Institute of Mental Health 44
Johns Hopkins University 45
Clinical Trial Overview of Johns Hopkins University 45
University of Florida 46
Clinical Trial Overview of University of Florida 46
Massachusetts General Hospital 47
Clinical Trial Overview of Massachusetts General Hospital 47
Washington University School of Medicine 48
Clinical Trial Overview of Washington University School of Medicine 48
New York University School of Medicine 49
Clinical Trial Overview of New York University School of Medicine 49
Baylor College of Medicine 50
Clinical Trial Overview of Baylor College of Medicine 50
Five Key Clinical Profiles 51
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 72